辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PFE 辉瑞

休市中 04-02 16:00:00 EDT

28.32

-0.23

-0.81%

盘后28.30

-0.02-0.07%

19:59 EDT

最高28.75	最低28.22	成交量3,092万
今开28.50	昨收28.55	日振幅1.84%
总市值1,610亿	流通市值1,607亿	总股本56.86亿
成交额8.79亿	换手率0.54%	流通股本56.76亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PFE","market":"US","secType":"STK","nameCN":"辉瑞","latestPrice":28.32,"timestamp":1775160000000,"preClose":28.55,"halted":0,"volume":30920609,"hourTrading":{"tag":"盘后","latestPrice":28.2999,"preClose":28.32,"latestTime":"19:59 EDT","volume":4688338,"amount":132769702.4194,"timestamp":1775174397724,"change":-0.0201,"changeRate":-0.00071,"amplitude":0.003884},"delay":0,"changeRate":-0.008056042031523658,"floatShares":5675908374,"shares":5685707552,"eps":1.36,"marketStatus":"休市中","change":-0.23,"latestTime":"04-02 16:00:00 EDT","open":28.5,"high":28.745,"low":28.22,"amount":879054825.313735,"amplitude":0.018389,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.36,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-819144000000,"exchange":"NYSE","adjPreClose":28.55,"dividendRate":0.060731,"preHourTrading":{"tag":"盘前","latestPrice":28.46,"preClose":28.55,"latestTime":"09:29 EDT","volume":115939,"amount":3288023.08366,"timestamp":1775136599432,"change":-0.09,"changeRate":-0.003152,"amplitude":0.006263},"postHourTrading":{"tag":"盘后","latestPrice":28.2999,"preClose":28.32,"latestTime":"19:59 EDT","volume":4688338,"amount":132769702.4194,"timestamp":1775174397724,"change":-0.0201,"changeRate":-0.00071,"amplitude":0.003884},"volumeRatio":0.7984754450590722,"optionData":{"bulkOrders":[{"symbol":"PFE","call":false,"expireDate":1813204800000,"strike":"27.0","timestamp":1775141217097,"price":2.72,"volume":5000,"amount":1360000,"type":"+"},{"symbol":"PFE","call":false,"expireDate":1776398400000,"strike":"25.0","timestamp":1775146888814,"price":0.03,"volume":2400,"amount":7200,"type":"-"}]},"impliedVol":0.2895,"impliedVolPercentile":0.5538},"requestUrl":"/m/hq/s/PFE","defaultTab":"news","newsList":[{"id":"1185865281","title":"官宣：美国对钢铝铜衍生品征收25%关税，对专利药征100%关税，但遵守协议“豁免”","url":"https://stock-news.laohu8.com/highlight/detail?id=1185865281","media":"华尔街见闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185865281?lang=zh_cn&edition=full","pubTime":"2026-04-03 07:04","pubTimestamp":1775171049,"startTime":"0","endTime":"0","summary":"在医药关税方面，美国将对“拥有品牌或专利”的进口药品和制药成分征收100%的关税，但已经同特朗普政府达成协议的国家地区和药企可以得到豁免。新规意味着，特朗普政府将对钢铁、铝以及铜及其衍生品统一征收25%关税，关税覆盖范围从原材料延伸至下游制成品，政策目标明确指向“防止规避现有关税体系”。对于仅与美国商务部签署回流生产协议的企业，将适用20%的关税税率。","market":"us","thumbnail":"https://static.tigerbbs.com/627bc890436e46f74a0fe8143398a725","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/627bc890436e46f74a0fe8143398a725"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0ce0ad734d181460da5100451b35d0fa","theme_name":"热榜No.20 · 美国调整钢铝铜关税及专利药品征税政策","theme_type":2,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3769140","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1762389672944","symbols":["X","PFE"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2624529418","title":"辉瑞和BioNTech停止在美国的一项新冠疫苗研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2624529418","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624529418?lang=zh_cn&edition=full","pubTime":"2026-04-02 10:26","pubTimestamp":1775096794,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SG9999003800.SGD","PFE","LU0225284248.USD","LU1066053197.SGD","BK4550","BK4534","SG9999011175.SGD","LU0306807586.USD","IE00BBT3K403.USD","SG9999002232.USD","LU0170899867.USD","BK4568","LU1883839398.USD","SG9999001176.USD","LU0225771236.USD","LU1057294990.SGD","BK4007","LU0321505439.SGD","LU0868494617.USD","LU1894683348.USD","BK4581","LU1066051498.USD","BK4588","SG9999001176.SGD","BK4585","IE00B19Z3B42.SGD","IE00B19Z3581.USD","IE00BLSP4239.USD","SG9999002224.SGD","BK4592","LU0985481810.HKD","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU1894683264.USD","LU0289739699.SGD","LU1023059063.AUD","LU0306806265.USD","IE00BLSP4452.SGD","BK4599","LU0234572021.USD","IE0002270589.USD","LU0321505868.SGD","LU0122379950.USD","BNTX","BK4533","LU0058720904.USD","SG9999013999.USD","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624526907","title":"英国扩大RSV防线!辉瑞(PFE.US)RSV疫苗覆盖范围从75岁扩至80岁以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2624526907","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624526907?lang=zh_cn&edition=full","pubTime":"2026-04-02 09:33","pubTimestamp":1775093611,"startTime":"0","endTime":"0","summary":"周四公布的这一决定是在现有项目基础上的全面扩展，此前该项目覆盖的是75岁至79岁人群。葛兰素史克在英国推出的是一款面向老年人的竞争性疫苗，而阿斯利康则在英国推出的是一款用于保护婴儿免受RSV侵害的药物。RSV疫苗对老年群体可谓非常重要，可以说是高龄呼吸道预防体系中的关键一环。英国方面之所以把辉瑞Abrysvo的接种范围从75至79岁扩大到80岁及以上，重要依据之一则是上述的新证据显示，接种后因RSV住院的风险可下降约75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"英国扩大RSV防线!辉瑞(PFE.US)RSV疫苗覆盖范围从75岁扩至80岁以上","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0306807586.USD","LU0321505439.SGD","IE00BBT3K403.USD","LU0868494617.USD","BK4588","BK4007","SG9999011175.SGD","LU0289739699.SGD","BK4550","LU0058720904.USD","IE00BLSP4452.SGD","BK4585","LU0306806265.USD","SG9999013999.USD","LU0985481810.HKD","BK4599","LU0456855351.SGD","BK4592","SG9999001176.SGD","LU0225284248.USD","LU0170899867.USD","LU1883839398.USD","LU1057294990.SGD","LU1066053197.SGD","BK4568","IE00B19Z3581.USD","LU0234572021.USD","LU1894683348.USD","SG9999001176.USD","SG9999002232.USD","SG9999002224.SGD","LU0225771236.USD","BK4533","LU0122379950.USD","PFE","IE00B19Z3B42.SGD","SGXZ57979304.SGD","BK4534","LU1023059063.AUD","LU1894683264.USD","IE0002270589.USD","SG9999003800.SGD","IE00BLSP4239.USD","IE000M9KFDE8.USD","LU1066051498.USD","BK4581","LU0321505868.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624526333","title":"辉瑞赢得波兰和罗马尼亚新冠疫苗诉讼案，将获赔22亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624526333","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624526333?lang=zh_cn&edition=full","pubTime":"2026-04-02 09:32","pubTimestamp":1775093542,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SG9999003800.SGD","PFE","LU0985481810.HKD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU0456855351.SGD","LU0225771236.USD","IE00B19Z3581.USD","LU0122379950.USD","SGXZ57979304.SGD","LU1057294990.SGD","BK4585","SG9999001176.USD","BK4007","LU0225284248.USD","LU0306806265.USD","LU1894683348.USD","LU1883839398.USD","BK4568","BK4533","LU0868494617.USD","SG9999013999.USD","BK4599","IE00BLSP4452.SGD","LU0170899867.USD","BK4592","LU1023059063.AUD","BK4550","SG9999002224.SGD","BK4534","LU1894683264.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999001176.SGD","LU0289739699.SGD","BK4581","LU0058720904.USD","SG9999011175.SGD","LU0321505868.SGD","LU0234572021.USD","LU1066051498.USD","IE0002270589.USD","LU0306807586.USD","LU0321505439.SGD","SG9999002232.USD","IE000M9KFDE8.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156657448","title":"消息称特朗普拟对部分制药企业征收新关税","url":"https://stock-news.laohu8.com/highlight/detail?id=1156657448","media":"老虎资讯综合","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156657448?lang=zh_cn&edition=full","pubTime":"2026-04-02 07:45","pubTimestamp":1775087120,"startTime":"0","endTime":"0","summary":"某些药物和疾病类别也可能获得豁免。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"558a26cfa5754234b2e7f202aad8ac05","theme_name":"热榜No.3 · 特朗普最新动态","theme_type":2,"isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","NVO","PFE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122810902","title":"辉瑞与合作伙伴BioNTech宣布：因招募缓慢将终止美国50至64岁健康成年人新冠疫苗研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1122810902","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122810902?lang=zh_cn&edition=full","pubTime":"2026-04-01 23:35","pubTimestamp":1775057741,"startTime":"0","endTime":"0","summary":"辉瑞与合作伙伴BioNTech SE近日宣布，由于受试者招募进度未达预期，将终止针对美国50至64岁健康成年人群的新冠疫苗临床研究项目。两家公司透露，该年龄组志愿者的入组速度显著低于计划目标，导致研究难以按原定方案推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","BK4581","IE000M9KFDE8.USD","BK4599","SG9999001176.SGD","LU1066053197.SGD","LU0868494617.USD","SG9999003800.SGD","BK4585","LU1023059063.AUD","BK4548","LU0321505868.SGD","LU1057294990.SGD","LU0225284248.USD","LU1066051498.USD","BNTX","BK4534","SG9999002224.SGD","BK4533","LU0058720904.USD","SG9999001176.USD","SG9999002232.USD","BK4588","SG9999011175.SGD","BK4550","BK4568","LU1894683264.USD","LU1883839398.USD","LU0122379950.USD","LU0985481810.HKD","LU0170899867.USD","BK4535","SGXZ57979304.SGD","PFE","IE00BLSP4239.USD","LU0289739699.SGD","LU0225771236.USD","BK4139","BK4592","LU0234572021.USD","LU0306806265.USD","IE00B19Z3B42.SGD","BK4007","IE00BBT3K403.USD","BK4551","IE00B19Z3581.USD","IE0002270589.USD","LU0456855351.SGD","SG9999013999.USD","IE00BLSP4452.SGD","LU0321505439.SGD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624516413","title":"辉瑞撤离南旧金山 此地员工将转为远程办公岗位","url":"https://stock-news.laohu8.com/highlight/detail?id=2624516413","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624516413?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:58","pubTimestamp":1775048337,"startTime":"0","endTime":"0","summary":"辉瑞正准备于4月底关闭其位于南旧金山的研发基地和办公室。这似乎是该公司从生物技术领域最重要区域之一大幅撤退的举措。辉瑞于2022年以54亿美元收购了该公司。当时人们认为这笔交易是辉瑞产品线向前迈进的一大步。　　辉瑞表示，该办公室使用率不足，目前在此工作的员工将转为远程办公岗位。辉瑞一直面临削减成本、优化产品线以及将资金投向能获得最高长期回报领域方面的压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-01/doc-inhszayv8422587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LU1057294990.SGD","IE000M9KFDE8.USD","BK4568","BK4534","IE00B19Z3B42.SGD","LU0225284248.USD","LU0170899867.USD","BK4599","LU1894683264.USD","IE00BLSP4239.USD","LU0868494617.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4588","BK4533","LU1023059063.AUD","LU1066051498.USD","LU0122379950.USD","BK4592","LU1883839398.USD","LU1894683348.USD","LU0321505439.SGD","LU0234572021.USD","SG9999002224.SGD","LU0225771236.USD","IE00BBT3K403.USD","SG9999002232.USD","LU0289739699.SGD","PFE","LU0306806265.USD","BK4550","LU0985481810.HKD","SG9999001176.SGD","LU0456855351.SGD","BK4581","LU1066053197.SGD","LU0321505868.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU0306807586.USD","SG9999001176.USD","SG9999011175.SGD","LU0058720904.USD","BK4585","IE00BLSP4452.SGD","SG9999013999.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623582570","title":"辉瑞(PFE.US)偏头痛口服预防药物在华申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2623582570","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623582570?lang=zh_cn&edition=full","pubTime":"2026-03-31 21:19","pubTimestamp":1774963198,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月31日，CDE网站显示，辉瑞(PFE.US)的硫酸瑞美吉泮口崩片在华申报新适应症，用于预防性治疗成人阵发性偏头痛。瑞美吉泮是全球首个且唯一个采用专利口崩片技术的降钙素基因相关肽(CGRP)受体拮抗剂，于2020年2月首次获FDA批准上市，用于急性治疗成人急性偏头痛。2021年5月，瑞美吉泮在美国扩展新适应症，用于预防成人发作性偏头痛。2024年1月，该药物首次在中国获批上市。据辉瑞财报，瑞美吉泮在2025年的全球销售额为14.24亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423321.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0122379950.USD","BK4534","LU0868494617.USD","IE0002270589.USD","LU0170899867.USD","LU0306807586.USD","LU1023059063.AUD","SG9999011175.SGD","IE00BBT3K403.USD","BK4585","BK4581","SG9999013999.USD","LU0321505868.SGD","LU0225284248.USD","LU1066051498.USD","SG9999001176.USD","LU0456855351.SGD","SG9999003800.SGD","IE00B19Z3581.USD","IE00BLSP4239.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU0234572021.USD","BK4592","LU1066053197.SGD","LU1057294990.SGD","LU1894683264.USD","BK4599","IE00BLSP4452.SGD","LU0058720904.USD","BK4533","SGXZ57979304.SGD","LU0985481810.HKD","LU0289739699.SGD","LU1894683348.USD","BK4550","BK4568","LU0225771236.USD","PFE","IE00B19Z3B42.SGD","SG9999002232.USD","BK4588","LU0321505439.SGD","BK4007","LU1883839398.USD","SG9999002224.SGD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621095724","title":"辉瑞报告莱姆病疫苗有效性达73%，试验结果使前景复杂化","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095724","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621095724?lang=zh_cn&edition=full","pubTime":"2026-03-24 22:58","pubTimestamp":1774364280,"startTime":"0","endTime":"0","summary":"随着其莱姆病疫苗试验的早期数据开始显现，辉瑞正接近其后疫情时代转型中一个潜在的重要转折点，尽管这一结果可能仍会留有争议空间。该公司报告称，与瓦尔内瓦公司合作开发的实验性疫苗针对这种蜱传疾病显示出73%的有效性，但研究中观察到的感染病例数量低于预期，使得总体有效性的全面解读变得更为困难。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-24/doc-inhschns4072029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["IE00BLSP4452.SGD","BK4585","SG9999002232.USD","IE00BLSP4239.USD","SG9999001176.SGD","LU0289739699.SGD","SG9999002224.SGD","BK4550","PFE","LU0225771236.USD","LU0321505868.SGD","SG9999011175.SGD","LU0456855351.SGD","LU1894683264.USD","SG9999001176.USD","BK4588","IE000M9KFDE8.USD","LU0225284248.USD","LU1023059063.AUD","IE00BBT3K403.USD","LU0306806265.USD","SG9999003800.SGD","BK4592","LU0306807586.USD","BK4568","LU0122379950.USD","IE00B19Z3B42.SGD","BK4599","BK4534","BK4007","SGXZ57979304.SGD","SG9999013999.USD","LU0985481810.HKD","LU1066051498.USD","BK4581","LU0321505439.SGD","LU1883839398.USD","LU0170899867.USD","IE0002270589.USD","LU1894683348.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1066053197.SGD","LU0058720904.USD","BK4533","LU0234572021.USD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621055728","title":"辉瑞莱姆病疫苗有效率73%，惟试验结果存不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2621055728","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621055728?lang=zh_cn&edition=full","pubTime":"2026-03-24 14:33","pubTimestamp":1774334009,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0225284248.USD","LU0868494617.USD","BK4007","SG9999002224.SGD","LU0058720904.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU0289739699.SGD","LU1057294990.SGD","BK4533","SG9999011175.SGD","BK4585","LU0985481810.HKD","LU0306807586.USD","LU0456855351.SGD","LU0306806265.USD","LU0321505439.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4550","LU1894683264.USD","LU0170899867.USD","BK4599","LU0321505868.SGD","IE00BBT3K403.USD","LU1023059063.AUD","SG9999002232.USD","LU0234572021.USD","LU1066053197.SGD","SG9999001176.USD","SG9999001176.SGD","BK4568","PFE","LU0122379950.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1883839398.USD","BK4592","SGXZ57979304.SGD","BK4534","LU0225771236.USD","BK4581","IE0002270589.USD","SG9999013999.USD","LU1894683348.USD","BK4588","SG9999003800.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119255139","title":"辉瑞与Valneva联合宣布：莱姆病候选疫苗在3期VALOR试验中展现强劲效力","url":"https://stock-news.laohu8.com/highlight/detail?id=1119255139","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119255139?lang=zh_cn&edition=full","pubTime":"2026-03-23 18:48","pubTimestamp":1774262917,"startTime":"0","endTime":"0","summary":"辉瑞与Valneva SE今日共同公布，其合作研发的莱姆病候选疫苗在关键性3期VALOR临床试验中取得了显著的疗效数据。该试验结果证实，疫苗在预防莱姆病方面表现出强有力的保护作用，标志着这一备受关注的传染病预防项目取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","LU1066051498.USD","LU1894683264.USD","SG9999003800.SGD","SG9999011175.SGD","LU0985481810.HKD","LU0170899867.USD","LU0456855351.SGD","LU0122379950.USD","BK4585","LU0058720904.USD","BK4599","LU0225284248.USD","LU0321505868.SGD","LU0868494617.USD","VALN","BK4581","BK4007","SG9999013999.USD","SGXZ57979304.SGD","LU1057294990.SGD","IE0002270589.USD","IE000M9KFDE8.USD","LU0321505439.SGD","BK4533","LU1023059063.AUD","LU1883839398.USD","LU1066053197.SGD","LU0225771236.USD","IE00BBT3K403.USD","LU1894683348.USD","BK4534","SG9999002232.USD","LU0289739699.SGD","BK4550","BK4592","IE00BLSP4452.SGD","SG9999001176.SGD","SG9999001176.USD","LU0306806265.USD","BK4588","LU0306807586.USD","IE00B19Z3581.USD","BK4568","PFE","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138718711","title":"辉瑞莱姆病候选疫苗Lb6v在五岁及以上人群中预防效力超70%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138718711","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138718711?lang=zh_cn&edition=full","pubTime":"2026-03-23 18:45","pubTimestamp":1774262748,"startTime":"0","endTime":"0","summary":"辉瑞公司宣布，其研发的莱姆病候选疫苗Lb6v在针对五岁及以上人群的临床试验中展现出卓越的预防效果，疫苗效力超过70%。这一数据为抗击由蜱虫传播的莱姆病提供了新的希望。\n研究结果表明，该疫苗在诱发人体免疫反应方面表现积极，能够有效降低莱姆病的感染风险。莱姆病若未及时治疗，可能引发神经系统及关节损伤等严重健康问题。\n此次进展标志着辉瑞在传染病疫苗领域取得重要突破，有望填补当前莱姆病预防领域的空白。下一步，辉瑞将继续推进疫苗的临床研发与监管申报工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999003800.SGD","LU0225771236.USD","SG9999002224.SGD","LU0985481810.HKD","LU1894683264.USD","SGXZ57979304.SGD","LU0456855351.SGD","SG9999001176.SGD","LU0306806265.USD","IE0002270589.USD","LU0170899867.USD","LU0122379950.USD","BK4550","LU0058720904.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","BK4585","PFE","LU0225284248.USD","LU0306807586.USD","LU1057294990.SGD","SG9999011175.SGD","LU0289739699.SGD","BK4592","LU0868494617.USD","BK4581","SG9999013999.USD","BK4533","BK4599","IE00BBT3K403.USD","LU0321505868.SGD","LU0321505439.SGD","LU1883839398.USD","BK4568","BK4534","LU1066051498.USD","BK4588","SG9999001176.USD","IE00BLSP4452.SGD","BK4007","LU1023059063.AUD","LU1894683348.USD","LU0234572021.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","SG9999002232.USD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132141086","title":"辉瑞：Lb6v候选疫苗耐受性良好 分析时未发现安全性问题","url":"https://stock-news.laohu8.com/highlight/detail?id=1132141086","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132141086?lang=zh_cn&edition=full","pubTime":"2026-03-23 18:45","pubTimestamp":1774262746,"startTime":"0","endTime":"0","summary":"辉瑞公司宣布，其研发的Lb6v候选疫苗在试验中表现出良好的耐受性，截至数据分析时，未发现任何安全性问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","LU0868494617.USD","BK4007","SG9999002224.SGD","LU0058720904.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU0289739699.SGD","LU1057294990.SGD","BK4533","SG9999011175.SGD","BK4585","LU0985481810.HKD","LU0306807586.USD","LU0456855351.SGD","LU0306806265.USD","LU0321505439.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4550","LU1894683264.USD","LU0170899867.USD","BK4599","LU0321505868.SGD","IE00BBT3K403.USD","LU1023059063.AUD","SG9999002232.USD","LU0234572021.USD","LU1066053197.SGD","SG9999001176.USD","SG9999001176.SGD","BK4568","PFE","LU0122379950.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1883839398.USD","BK4592","SGXZ57979304.SGD","BK4534","LU0225771236.USD","BK4581","IE0002270589.USD","SG9999013999.USD","LU1894683348.USD","BK4588","SG9999003800.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115629984","title":"辉瑞：Talzenna联合Xtandi安全性符合各自已知安全特征，未发现新安全信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1115629984","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115629984?lang=zh_cn&edition=full","pubTime":"2026-03-19 18:48","pubTimestamp":1773917316,"startTime":"0","endTime":"0","summary":"辉瑞公司公布的数据显示，Talzenna与Xtandi联合用药的安全性特征与两种药物各自已知的安全性数据保持一致，研究期间未出现新的安全性信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","LU0868494617.USD","BK4007","SG9999002224.SGD","LU0058720904.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU0289739699.SGD","LU1057294990.SGD","BK4533","SG9999011175.SGD","BK4585","LU0985481810.HKD","LU0306807586.USD","LU0456855351.SGD","LU0306806265.USD","LU0321505439.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4550","LU1894683264.USD","LU0170899867.USD","BK4599","LU0321505868.SGD","IE00BBT3K403.USD","LU1023059063.AUD","SG9999002232.USD","LU0234572021.USD","LU1066053197.SGD","SG9999001176.USD","SG9999001176.SGD","BK4568","PFE","LU0122379950.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1883839398.USD","BK4592","SGXZ57979304.SGD","BK4534","LU0225771236.USD","BK4581","IE0002270589.USD","SG9999013999.USD","LU1894683348.USD","BK4588","SG9999003800.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111610205","title":"Talzenna联合Xtandi显著改善转移性前列腺癌患者的影像学无进展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1111610205","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111610205?lang=zh_cn&edition=full","pubTime":"2026-03-19 18:46","pubTimestamp":1773917215,"startTime":"0","endTime":"0","summary":"一项最新研究显示，将Talzenna与Xtandi联合使用，可显著提升转移性前列腺癌患者的影像学无进展生存期。这一积极结果有望为晚期前列腺癌的治疗提供新的有效方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU0170899867.USD","LU0225284248.USD","PFE","IE00BLSP4239.USD","LU0289739699.SGD","LU0306807586.USD","LU0456855351.SGD","LU0306806265.USD","BK4581","LU1066053197.SGD","BK4568","BK4599","SG9999013999.USD","LU0225771236.USD","LU1023059063.AUD","LU1883839398.USD","IE00B19Z3581.USD","LU0234572021.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0868494617.USD","SG9999002224.SGD","LU0321505439.SGD","LU0321505868.SGD","BK4534","AZN","BK4550","SGXZ57979304.SGD","SG9999002232.USD","SG9999001176.SGD","LU1894683348.USD","BK4585","BK4592","BK4533","IE00BLSP4452.SGD","LU0122379950.USD","LU0058720904.USD","IE000M9KFDE8.USD","IE00BBT3K403.USD","SG9999001176.USD","SG9999003800.SGD","LU1066051498.USD","SG9999011175.SGD","LU1057294990.SGD","LU1894683264.USD","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620241259","title":"辉瑞(PFE.US)潜在“first-in-class”小分子组合疗法达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2620241259","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620241259?lang=zh_cn&edition=full","pubTime":"2026-03-18 21:21","pubTimestamp":1773840109,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，辉瑞3月18日宣布，其2期FOURLIGHT-1研究达到主要终点。该积极结果支持辉瑞推进atirmociclib在一线治疗及早期疾病中的开发策略，在这些人群中，实现更持久的内分泌治疗疾病控制，有望带来更大的临床获益。Atirmociclib是一种在研、潜在“first-in-class”的口服CDK4抑制剂。该药物由辉瑞发现，目前正用于开发治疗HR阳性、HER2阴性乳腺癌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"辉瑞(PFE.US)潜在“first-in-class”小分子组合疗法达主要终点","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1023059063.AUD","LU0868494617.USD","BK4588","LU0306807586.USD","BK4568","IE00B19Z3B42.SGD","LU0170899867.USD","SG9999011175.SGD","LU0321505439.SGD","LU0456855351.SGD","SG9999001176.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU1066053197.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","SG9999002232.USD","LU0289739699.SGD","LU0234572021.USD","BK4007","BK4534","LU1894683264.USD","BK4592","SGXZ57979304.SGD","LU0306806265.USD","PFE","LU0225284248.USD","IE00BLSP4452.SGD","BK4581","LU0321505868.SGD","SG9999003800.SGD","BK4599","LU0122379950.USD","IE0002270589.USD","SG9999001176.SGD","LU1894683348.USD","LU1066051498.USD","IE00B19Z3581.USD","LU0058720904.USD","BK4585","LU1057294990.SGD","SG9999002224.SGD","SG9999013999.USD","BK4550","LU0225771236.USD","LU1883839398.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620477004","title":"辉瑞公布中期乳腺癌试验积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2620477004","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620477004?lang=zh_cn&edition=full","pubTime":"2026-03-18 03:11","pubTimestamp":1773774660,"startTime":"0","endTime":"0","summary":"辉瑞公司报告称，其实验性乳腺癌药物atirmociclib在一项中期临床试验中达到了主要目标。　　2期FOURLIGHT-1研究在患有激素受体阳性、HER2阴性的晚期或转移性乳腺癌的个体中，考察了atirmociclib联合fulvestrant的效果。辉瑞报告称，该药物的安全性特征易于管理，约有6%的患者因不良事件而停止治疗。　　辉瑞还希望在即将召开的医学会议上展示另一项针对早期乳腺癌的2期研究的结果。　　这些发现支持了辉瑞扩大其肿瘤学产品组合的更大计划。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-18/doc-inhrivfh3611593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0225284248.USD","SG9999002232.USD","IE00B19Z3581.USD","SG9999001176.USD","BK4534","LU0289739699.SGD","LU1066051498.USD","BK4533","SGXZ57979304.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0456855351.SGD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU0321505439.SGD","BK4550","LU1883839398.USD","LU1894683264.USD","LU0122379950.USD","LU0225771236.USD","LU0234572021.USD","LU1066053197.SGD","BK4585","SG9999013999.USD","BK4588","LU0321505868.SGD","LU0170899867.USD","LU1894683348.USD","BK4599","LU0306806265.USD","LU0868494617.USD","IE0002270589.USD","BK4581","IE00BBT3K403.USD","SG9999003800.SGD","LU1023059063.AUD","LU0058720904.USD","BK4568","LU1057294990.SGD","PFE","IE000M9KFDE8.USD","LU0306807586.USD","SG9999002224.SGD","SG9999001176.SGD","BK4592","LU0985481810.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176607064","title":"辉瑞公布新一代Cdk4抑制剂Atirmociclib在二线转移性乳腺癌中的积极二期临床试验顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1176607064","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176607064?lang=zh_cn&edition=full","pubTime":"2026-03-17 18:46","pubTimestamp":1773744360,"startTime":"0","endTime":"0","summary":"辉瑞公司宣布，其研发的新一代Cdk4抑制剂Atirmociclib在针对二线转移性乳腺癌患者开展的二期临床试验中取得了积极的顶线结果。这一进展标志着该药物在治疗晚期乳腺癌方面展现出潜在疗效，为后续临床开发奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","SG9999002232.USD","LU0170899867.USD","LU1894683348.USD","SG9999001176.SGD","LU1057294990.SGD","BK4588","BK4585","IE000M9KFDE8.USD","LU0058720904.USD","SG9999001176.USD","IE0002270589.USD","SG9999013999.USD","LU1066051498.USD","LU1883839398.USD","SG9999011175.SGD","LU0306807586.USD","BK4550","PFE","LU0122379950.USD","LU0321505868.SGD","LU0225771236.USD","LU0234572021.USD","LU1023059063.AUD","LU1894683264.USD","BK4581","LU0985481810.HKD","LU0225284248.USD","IE00B19Z3B42.SGD","LU0321505439.SGD","IE00BBT3K403.USD","BK4568","SG9999003800.SGD","BK4007","LU0456855351.SGD","SGXZ57979304.SGD","LU0868494617.USD","SG9999002224.SGD","IE00BLSP4239.USD","LU0289739699.SGD","IE00BLSP4452.SGD","IE00B19Z3581.USD","BK4534","LU1066053197.SGD","BK4592","LU0306806265.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153474703","title":"医疗保健板块动态：市场焦点解读","url":"https://stock-news.laohu8.com/highlight/detail?id=1153474703","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153474703?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304243,"startTime":"0","endTime":"0","summary":"0304 GMT——野村证券分析师指出，Celltrion今年的增长动力或将来自新一代生物类似药，而非传统主力产品。Zymfentra、Yuflyma、Vegzelma及Steqeyma等新上市生物类似药有望支撑该业绩指引，而Remsima、Truxima与Herzuma等经典产品则持续提供稳定收入。分析师补充道，这些\"新生代产品组合\"占比有望突破当前50%的水平，或将推动公司开启独立于传统旗舰产品的新盈利周期。巴黎CAC 40指数下跌0.6%，主导该指数的奢侈品板块集体下挫。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","XLV","BK4568","LU0306807586.USD","IE000M9KFDE8.USD","LU1057294990.SGD","LU1894683348.USD","XBI","SG9999001176.SGD","SG9999002224.SGD","LU1894683264.USD","BK4599","SG9999003800.SGD","SG9999011175.SGD","IE00B19Z3B42.SGD","BK4588","LU0225284248.USD","SG9999001176.USD","SGXZ57979304.SGD","LU0289739699.SGD","IE0002270589.USD","BK4585","LU1066053197.SGD","LU1023059063.AUD","BK4007","LABU","PFE","SG9999013999.USD","BK4533","LU1066051498.USD","LU0170899867.USD","IE00B19Z3581.USD","LU0225771236.USD","LU0868494617.USD","LU0306806265.USD","LU0985481810.HKD","LU0122379950.USD","BK4534","LU0234572021.USD","BK4550","BK4592","IE00BLSP4239.USD","BK4581","LU1883839398.USD","SG9999002232.USD","IE00BBT3K403.USD","LU0321505439.SGD","IE00BLSP4452.SGD","LU0456855351.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618853906","title":"还没进临床，就融了10亿：华人创立眼科biotech为何屡获巨头押注？","url":"https://stock-news.laohu8.com/highlight/detail?id=2618853906","media":"药融圈","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618853906?lang=zh_cn&edition=full","pubTime":"2026-03-12 09:34","pubTimestamp":1773279273,"startTime":"0","endTime":"0","summary":"CTX203旨在稳定一种名为ABCA1的蛋白质的表达水平，这种蛋白质与视网膜细胞中的脂质运输过程密切相关。合作初期将聚焦于AMD，并有望拓展至其他眼部疾病。根据协议条款，Character Bio已获得一笔首付款及年度研究资金，并有资格获得与后续开发及销售相关的里程碑付款，以及未来产品销售额的分级特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312102852a462a024&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312102852a462a024&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2098885051.SGD","LU0056508442.USD","IE0004445239.USD","BK4575","LU0889565833.HKD","LU1861558580.USD","LU1923623000.USD","LU1064131342.USD","LU1242518931.SGD","AMDL","AMDW","LU0719512351.SGD","LU0082616367.USD","LU1316542783.SGD","BK4612","AMD","BK4614","AMDG","AMDD","IE0009356076.USD","BK4543","SNY","LU1880398471.USD","BK4141","LU1880398554.USD","LU1861559042.SGD","LU0390134368.USD","LU0274383776.USD","LU0823421416.USD","DAMD","APLS","LU0642271901.SGD","LU1242518857.USD","BK4585","LU1303367103.USD","LU2355687059.USD","LU0823434583.USD","BK4512","BK4534","LU0081259029.USD","LU1803068979.SGD","IE00B5949003.HKD","LU0109392836.USD","PFE","BK4573","LU0823434740.USD","BK4566","LU0823421333.USD","AMDY","LU2264538146.SGD","LU1951198990.SGD","IE00BMPRXN33.USD","AMUU","IE00BMPRXR70.SGD","BK4554","LU1988902786.USD","LU2089985449.USD","LU1989764664.SGD","LU2931357623.SGD","LU2458330169.SGD","LU2250418816.HKD","AMYY","BHC","LU1951200564.SGD","AMDU","BK4532","LU2054465674.USD","LU1852331112.SGD","LU2360106780.USD","RHHBY","LU0127658192.USD","BK4605","BK4529","LU2458330243.SGD","BK4588","LU0198837287.USD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.pfizer.com","stockEarnings":[{"period":"1week","weight":0.0272},{"period":"1month","weight":0.0655},{"period":"3month","weight":0.1247},{"period":"6month","weight":0.0347},{"period":"1year","weight":0.1466},{"period":"ytd","weight":0.1373}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源，通过发现、开发、制造和分销保健产品（包括创新药物和疫苗），为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作，致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作，支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.456522,"avgChangeRate":0.002542},{"month":2,"riseRate":0.456522,"avgChangeRate":-0.005934},{"month":3,"riseRate":0.608696,"avgChangeRate":0.014732},{"month":4,"riseRate":0.595745,"avgChangeRate":0.018047},{"month":5,"riseRate":0.5,"avgChangeRate":0.007748},{"month":6,"riseRate":0.5,"avgChangeRate":0.002798},{"month":7,"riseRate":0.478261,"avgChangeRate":0.011357},{"month":8,"riseRate":0.456522,"avgChangeRate":0.0002},{"month":9,"riseRate":0.456522,"avgChangeRate":0.004432},{"month":10,"riseRate":0.630435,"avgChangeRate":0.013042},{"month":11,"riseRate":0.695652,"avgChangeRate":0.028255},{"month":12,"riseRate":0.5,"avgChangeRate":0.008452}],"exchange":"NYSE","name":"辉瑞","nameEN":"Pfizer"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辉瑞,PFE,辉瑞股票,辉瑞股票老虎,辉瑞股票老虎国际,辉瑞行情,辉瑞股票行情,辉瑞股价,辉瑞股市,辉瑞股票价格,辉瑞股票交易,辉瑞股票购买,辉瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}